Clinical trial
Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major…
NCT00223197 · University of Texas Southwestern Medical Center, Other · Completed
Key facts
| NCT number | NCT00223197 |
|---|---|
| Title | Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major Depressive Disorder With Substance Abuse |
| Official title | A Double-blind Placebo Controlled Trial of Pregnenolone for Depression in Patients With Bipolar Disorders or Recurrent Major Depressive Disorder and a History of Substance Abuse |
| Lead sponsor | University of Texas Southwestern Medical Center, Other |
| Collaborators | Stanley Medical Research Institute |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder, Major Depressive Disorder, Substance Abuse |
| Intervention type | Drug |
| Interventions | Pregnenolone |
| Enrollment | 75 |
| Start date | Feb 1, 2004 |
| Completion | Apr 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Apr 3, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: